Latest Schedule 13G passive stakes

State Street Corporation has disclosed beneficial ownership of 5.5% of Viridian Therapeutics Inc.'s common stock as of June 30, 2026.

FMR LLC, along with Abigail P. Johnson, has reported a beneficial ownership of 10.1% in Hayward Holdings Inc. common stock as of July 31, 2026.

State Street Corporation and SSGA Funds Management, Inc. have reported their beneficial ownership of Virgin Galactic Holdings Inc. common stock as of June 30, 2026.

State Street Corporation and SSGA Funds Management, Inc. have reported their beneficial ownership of Virgin Galactic Holdings Inc. common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5.9% of Vir Biotechnology Inc.'s common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5.9% of Vir Biotechnology Inc.'s common stock as of June 30, 2026.

River Road Asset Management, LLC has disclosed an increased beneficial ownership of CoreCivic, Inc. common stock, now holding 7.3% of the class.

State Street Corporation has disclosed beneficial ownership of 5.8% of Verastem Inc.'s common stock, holding over 5.1 million shares.

State Street Corporation has disclosed beneficial ownership of 5.8% of Verastem Inc.'s common stock, holding over 5.1 million shares.

FMR LLC and Abigail P. Johnson have filed a Schedule 13G amendment, reporting zero shares beneficially owned in Expro Group Holdings NV as of July 31, 2026.

State Street Corporation has disclosed beneficial ownership of 5.8% of Vera Therapeutics Inc. common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5.8% of Vera Therapeutics Inc. common stock as of June 30, 2026.

State Street Corporation and its affiliate SSGA Funds Management, Inc. have updated their beneficial ownership filings for Ur-Energy Inc., reporting a combined 6.6% stake.

State Street Corporation and its affiliate SSGA Funds Management, Inc. have updated their beneficial ownership filings for Ur-Energy Inc., reporting a combined 6.6% stake.

FMR LLC and Abigail P. Johnson have filed a Schedule 13G, reporting 0.00 shares beneficially owned in Xoma Royalty Corporation as of July 31, 2026.

State Street Corporation has reported beneficial ownership of 6.4% of Uranium Energy Corp's common stock as of June 30, 2026.

State Street Corporation has reported beneficial ownership of 6.4% of Uranium Energy Corp's common stock as of June 30, 2026.

State Street Corporation has updated its beneficial ownership filing for UnitedHealth Group common stock, reporting a 5% stake as of June 30, 2026.

State Street Corporation has updated its beneficial ownership filing for UnitedHealth Group common stock, reporting a 5% stake as of June 30, 2026.

State Street Corporation and SSGA Funds Management, Inc. have updated their Schedule 13G filing, reporting a combined beneficial ownership of 7.7% in United States Antimony Corp.

State Street Corporation and SSGA Funds Management, Inc. have updated their Schedule 13G filing, reporting a combined beneficial ownership of 7.7% in United States Antimony Corp.

Geode Capital Management and Geode Capital Holdings have disclosed their beneficial ownership of Liberty Capital Corporation's Series A GCI Group Common Stock, collectively holding a significant percentage.

State Street Corporation has reported beneficial ownership of 6,158,766 shares, representing 6.3% of the outstanding common stock of Ultragenyx Pharmaceutical Inc., as of June 30, 2026.

State Street Corporation has reported beneficial ownership of 6,158,766 shares, representing 6.3% of the outstanding common stock of Ultragenyx Pharmaceutical Inc., as of June 30, 2026.

FMR LLC and Abigail P. Johnson have filed an amendment to Schedule 13G, reporting beneficial ownership of 7.0% of Cheesecake Factory Inc.'s common stock as of July 31, 2026.

FMR LLC, through its subsidiaries, has reported a beneficial ownership of 8.3% of CBIZ Inc.'s common stock as of July 31, 2026.

FMR LLC, along with Abigail P. Johnson, has reported beneficial ownership of 7.2% of Byrna Technologies' common stock as of July 31, 2026.

FMR LLC and Abigail P. Johnson have reported a beneficial ownership stake of 1.9% in Capri Holdings Ltd as of July 31, 2026.

FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing, reporting beneficial ownership of 10.8% of Avalo Therapeutics Inc.'s common stock as of July 31, 2026.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 10.3% in Xenon Pharmaceuticals Inc. common stock as of July 31, 2026.